WineBoard
cholesteral reducing white wine grape? - Printable Version

+- WineBoard (https://www.wines.com/wineboard)
+-- Forum: GENERAL (https://www.wines.com/wineboard/forum-100.html)
+--- Forum: For the Novice (https://www.wines.com/wineboard/forum-2.html)
+--- Thread: cholesteral reducing white wine grape? (/thread-16079.html)



- Rebecca Ann - 06-12-2003

Someone told me that there is a grape used to make white wines, that has the health benefits of red wine producing grapes (lowering cholesteral). Does anyone know the name of this grape or any other pertinent information?
Thanks!


- Bucko - 06-12-2003

There is no wine grape that lowers cholesterol. You were misinformed.


- wondersofwine - 06-12-2003

Welcome to the board, Rebecca Ann. Drink wine for other reasons--enjoyment, education, antioxidants.


- Bucko - 06-12-2003

BTW, the mechanism of cardioprotection from wine is by the ELEVATION of HDL cholesterol (good fraction).


- curious - 06-13-2003

just wondering, could it be that the person who said it helped cholesterol have been thinking that by raising the good levels, it would lower the bad levels?

Ignorumus like me about medical issues might be confused and perceive it that way. The focus I have on health is mental, not physical (I know they interlink, but you all know what I mean).

Curious (Janette)


- Redman - 06-14-2003

By raising your HDL you lower your LDL/HDL ratio.

Numerous scientific medical studies have concluded that lowering your LDL/HDL ratio is cardio protective.
Drinking red wine helps to lower your LDL/HDL ratio - so too does exercise, eating grains, fruits, vegetables & not smoking :-)


Redman


- Bucko - 06-14-2003

Smoking is a risk factor for heart attack and stroke independent of the cholesterol level.


- Redman - 06-14-2003

Smoking lowers your HDL.

Cheers

Redman


- winoweenie - 06-14-2003

Hi Redman and just a lil' tip....unless you're a M.D. wouldn't get into a whizzing contest with DR. Buckner (affectionately known as Bucko ) on health issues. WW


- Bucko - 06-14-2003

No, Redman is right. However, smoking exerts its main effects on LDL from all of my readings. LDL must be in an oxidized form to do its nasty stuff with atheromas/cholesterol plaques. Because smoking is associated with increased lipid peroxidation, it activates more LDL, thus increasing risk of cardiovascular disease.

Here is one abstract:

Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers.

Free Radic Biol Med 2001 May 15;30(10):1122-9 (ISSN: 0891-5849)

van Tits LJ; de Waart F; Hak-Lemmers HL; van Heijst P; de Graaf J; Demacker PN; Stalenhoef AF
Department of Medicine, Division of General Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands. B.vantits@aig.azn.nl.

Antioxidants have been postulated to exert beneficial effects in atherosclerosis. Atherosclerosis is associated with raised plasma levels of soluble intercellular adhesion molecule-1 (sICAM-1) and autoantibodies against oxidized low-density lipoprotein (oxLDL). It is not known whether antioxidants affect these plasma factors in chronic smokers. In a randomized double-blind placebo-controlled study involving 128 male normolipidemic chronic smokers the effect of a 2-year alpha-tocopherol treatment (400 IU dL-alpha-tocopherol daily) on plasma levels of sICAM-1 and autoantibodies against oxLDL was evaluated. In addition, we monitored production of superoxide by leukocytes ex vivo. It was found that compared to nonsmokers (n = 33) plasma levels of IgG but not IgM autoantibodies against oxLDL and concentrations of sICAM-1 in smokers were significantly elevated (30 and 42%, respectively). After supplementation with alpha-tocopherol concentration of TBARS in plasma and in vitro oxidizability of LDL had decreased, but autoantibodies and sICAM-1 had not changed. Production of superoxide was not different between alpha-tocopherol- and placebo-treated smokers. It is concluded that in chronic smokers, long-term treatment with alpha-tocopherol does not normalize the raised levels of sICAM-1 and autoantibodies against oxLDL, both risk factors for initiation or progression of cardiovascular disease, despite a decrease in in vitro oxidizability of LDL.

Here is an abstract that does show some effects of smoking and lowered HDL:

The interrelationship among tobacco consumption, high-density lipoprotein cholesterol and leukocyte counts.

J Cardiovasc Risk 1997 Aug;4(4):279-81 (ISSN: 1350-6277)

Celada MM; Reguero JR; Cubero GI
Servicio de Cardiologia, Hospital Universitario Central de Asturias, Oviedo, Spain.

BACKGROUND: Tobacco consumption is a major cardiovascular risk factor that has been related to changes in lipoprotein levels and in the leukocyte count. OBJECTIVE: To investigate the interrelationship among leukocytes, high-density lipoprotein (HDL) cholesterol levels and tobacco consumption. METHODS: In total 1022 healthy male miners aged 40.5+/-8 years (mean+/-SD) were evaluated consecutively during the period 1993-1994. We evaluated the smoking history of all of the subjects by means of a structured questionnaire. After the subject had fasted for 12 h we extracted blood samples by venepuncture. Plasma concentrations of HDL were determined enzymatically (by the CHOD-PAP method) and the leukocyte count was determined with an automatic analyser. Statistical analysis was performed using analysis of variance for the mean differences and the Pearson and stepwise tests to determine correlations. RESULTS: The leukocyte count was significantly lower (8.014+/-2.327/mm3, P < 0.05) in those subjects with levels of HDL cholesterol equal to or greater than 0.9 mmol/l in comparison with that in those with HDL cholesterol levels lower than 0.9 mmol/l (8.450+/-2.375/mm3). Leukocyte counts were correlated directly to tobacco consumption (r= 0.3119, P < 0.01) and inversely to H DL cholesterol levels (r = -0.1513, P < 0.01). HDL cholesterol levels were lower in smokers (1.15+/-0.31 mmol/l) and these differences were significant with respect to the levels in non-smokers (1.22+/-0.30 mmol/l, P<0.05) but not with respect to those in former smokers (1.21+/-0.39 mmol/l). The leukocyte count was significantly greater in smokers (8.963+/-2.428/mm3, P<0.05) than it was in former smokers (7.041+/-1.698/mm3) and in non-smokers (6.793+/-1.599/mm3). CONCLUSIONS: The results of this study indicate that tobacco consumption is associated with lower HDL cholesterol levels and higher leukocyte counts. Leukocyte counts correlate positively to tobacco consumption and inversely to HDL cholesterol levels. Subjects with HDL cholesterol levels lower than 0.9 mmol/l present with leukocyte counts higher than those found in those with HDL cholesterol values equal to or greater than 0.9 mmol/l.

All of that said, my original statement is still true -- smoking is a risk factor independent of cholesterol.


- winoweenie - 06-14-2003

Whatdiditoltyouse Redski?WW


- Thomas - 06-14-2003

...and Bucko, isn't it all alcohol that benefits HDL, not just red wine?


- Bucko - 06-14-2003

You are correct, Ron Rico 151 breath!


- Rebecca Ann - 06-15-2003

Just wanted to say thanks for all that information about HDL levels and the links it has to wine. I appreciate it!


- Thomas - 06-15-2003

I haven't had Ron Rico 151 since Friday...